MAC Lung Disease
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease (NCT05327803) | AN2 Therapeutics, Inc | 2022-05-20 |
| CLArithromycin Versus AZIthromycin in the Treatment of Mycobacterium Avium Complex (MAC) Lung Infections (NCT03236987) | Centre Hospitalier Universitaire, Amiens | 2018-02-05 |
Track MAC Lung Disease automatically
Every clearance here is in the API, with alerts when new ones post.